Trial Profile
A phase II trial of AP 1531 in patients with migraine.
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 26 Sep 2011
Price :
$35
*
At a glance
- Drugs AP 1531 (Primary)
- Indications Migraine
- Focus Therapeutic Use
- 21 Sep 2011 New trial record